drugset / Trial / NCT03152786

Propranolol Hydrochloride in Treating Patients With Prostate Cancer Undergoing Surgery

NCT03152786

RandomizedParallel-groupOpen-labelTreatment

Summary

This randomized pilot clinical trial studies how well propranolol hydrochloride works in treating patients with prostate cancer who are undergoing surgery. When stressed, the body makes a molecule that may prevent tumor cells from dying, and propranolol hydrochloride may affect the signals in cells that cause tumor cells survival and death.

Timeline

Start
2019-01-15
Primary completion
2021-06-15
Completion
2023-02-28

Drugs

EvaluationDrugModalityDoseRoute
Subject Propranolol Small molecule Oral

Indications